GABA and GABAA receptor changes in the substantia nigra of the rat following quinolinic acid lesions in the striatum closely resemble Huntington's disease

[1]  D. Tracey,et al.  Neurotransmitters in the Human Brain , 2012, Advances in Behavioral Biology.

[2]  R. Porsolt,et al.  Animal models of dementia , 1995 .

[3]  K. H. Backus,et al.  Stoichiometry of a recombinant GABAA receptor deduced from mutation-induced rectification. , 1993, Neuroreport.

[4]  S. Dunnett,et al.  Huntington's disease: animal models and transplantation repair , 1993, Current Opinion in Neurobiology.

[5]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[6]  F. Block,et al.  Quinolinic acid lesion of the striatum induces impairment in spatial learning and motor performance in rats , 1993, Neuroscience Letters.

[7]  R. Faull,et al.  The regional, cellular and subcellular localization of GABAA/benzodiazepine receptors in the substantia nigra of the rat , 1992, Neuroscience.

[8]  P. Malherbe,et al.  In situ hybridization histochemistry reveals a diversity of GABAA receptor subunit mRNAs in neurons of the rat spinal cord and dorsal root ganglia , 1991, Neuroscience.

[9]  R. Faull,et al.  Prolonged and selective induction of Fos-related antigen(s) in striatal neurons after 6-hydroxydopamine lesions of the rat substantia nigra pars compacta. , 1991, Brain research. Molecular brain research.

[10]  M. Beal,et al.  Chronic quinolinic acid lesions in rats closely resemble Huntington's disease , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  R. Faull,et al.  GABA, GABA receptors and benzodiazepine receptors in the human spinal cord: An autoradiographic and immunohistochemical study at the light and electron microscopic levels , 1990, Neuroscience.

[12]  M. Gobbi,et al.  Regional distribution of low-affinity GABA receptors coupled to benzodiazepine receptor subtypes in rat brain: an autoradiographic evaluation. , 1990, European journal of pharmacology.

[13]  Marian DiFiglia,et al.  Excitotoxic injury of the neostriatum: a model for Huntington's disease , 1990, Trends in Neurosciences.

[14]  E. Sigel,et al.  Functional characteristics and sites of gene expression of the alpha 1, beta 1, gamma 2-isoform of the rat GABAA receptor , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  B. Sakmann,et al.  Functional properties of recombinant rat GABAA receptors depend upon subunit composition , 1990, Neuron.

[16]  P. Seeburg,et al.  Type I and type II GABAA-benzodiazepine receptors produced in transfected cells. , 1989, Science.

[17]  M. Giordano,et al.  The quinolinic acid model of Huntington's disease: Locomotor abnormalities , 1989, Experimental Neurology.

[18]  S. Hunt,et al.  Localization of GABAA receptor α-subunit mRNAs in relation to receptor subtypes , 1989 .

[19]  P. Malherbe,et al.  Mapping of brain areas containing RNA homologous to cDNAs encoding the alpha and beta subunits of the rat GABAA gamma-aminobutyrate receptor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[20]  H. Mohler,et al.  Immunohistochemical localization of benzodiazepine/GABAA receptors in the human hippocampal formation , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[21]  R. Faull,et al.  Multiple benzodiazepine receptors in the human basal ganglia: A detailed pharmacological and anatomical study , 1988, Neuroscience.

[22]  M. Beal,et al.  Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease. , 1987, Brain : a journal of neurology.

[23]  A. Parent,et al.  Quinolinic acid does not spare striatal neuropeptide Y-immunoreactive neurons , 1987, Brain Research.

[24]  H. Mohler,et al.  Resolving GABAA/benzodiazepine receptors: cellular and subcellular localization in the CNS with monoclonal antibodies , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[25]  Joseph B. Martin,et al.  Patterns of cell loss in Huntington's disease , 1987, Trends in Neurosciences.

[26]  Joseph B. Martin,et al.  Morphologic and Histochemical Characteristics of a Spared Subset of Striatal Neurons in Huntington's Disease , 1987, Journal of neuropathology and experimental neurology.

[27]  W. Nauta,et al.  The visual cortico-striato-nigral pathway in the rat , 1986, Neuroscience.

[28]  J. Gusella,et al.  Huntington's disease. Pathogenesis and management. , 1986, The New England journal of medicine.

[29]  Joseph B. Martin,et al.  Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid , 1986, Nature.

[30]  R. Faull,et al.  Benzodiazepine receptors in the human spinal cord: A detailed anatomical and pharmacological study , 1986, Neuroscience.

[31]  G. Biggio,et al.  Striato-nigral denervation increases type II benzodiazepine receptors in the substantia nigra of the rat , 1986, Neuropharmacology.

[32]  J. B. Martin,et al.  Selective sparing of a class of striatal neurons in Huntington's disease. , 1985, Science.

[33]  P. Emson,et al.  Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease , 1985, Brain Research.

[34]  S. Folstein,et al.  Neurotransmitter receptor alterations in Huntington's disease: Autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes , 1985, Annals of neurology.

[35]  T. Staehelin,et al.  Monoclonal antibodies reveal structural homogeneity of gamma-aminobutyric acid/benzodiazepine receptors in different brain areas. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[36]  W. Haefely,et al.  Co-localization of GABAA receptors and benzodiazepine receptors in the brain shown by monoclonal antibodies , 1985, Nature.

[37]  G. Graveland,et al.  Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. , 1985, Science.

[38]  J. Penney,et al.  Benzodiazepine and GABA receptors in early Huntington's disease , 1984, Neurology.

[39]  J. Penney,et al.  Characterization of benzodiazepine receptor changes in substantia nigra, globus pallidus and entopeduncular nucleus after striatal lesions. , 1984, The Journal of pharmacology and experimental therapeutics.

[40]  S. Snyder,et al.  Differential localization of type I and type II benzodiazepine binding sites in substantia nigra , 1983, Nature.

[41]  R. Schwarcz,et al.  Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. , 1983, Science.

[42]  J. Penney,et al.  Quantitative autoradiography of neurotransmitter receptors in Huntington disease , 1982, Neurology.

[43]  Michael J. Kuhar,et al.  Quantitative receptor autoradiography using [3H]Ultrofilm: application to multiple benzodiazepine receptors , 1982, Journal of Neuroscience Methods.

[44]  M. Hayden,et al.  Huntington’s Chorea , 1981, Springer London.

[45]  W. Young,et al.  Multiple benzodiazepine receptor localization by light microscopic radiohistochemistry. , 1981, The Journal of pharmacology and experimental therapeutics.

[46]  D. Overstreet,et al.  Benzodiazepine receptors: The effect of GABA on their characteristics in human brain and their alteration in Huntington's disease , 1980, Brain Research.

[47]  W. Young,et al.  Radiohistochemical localization of benzodiazepine receptors in rat brain. , 1980, The Journal of pharmacology and experimental therapeutics.

[48]  B. Beer,et al.  Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors , 1979, Pharmacology Biochemistry and Behavior.

[49]  E. Bird,et al.  Alterations in the benzodiazepine receptor of Huntington's diseased human brain , 1979, Brain Research.

[50]  J. Waddington,et al.  Denervation supersensitivity in the striatonigral GABA pathway , 1978, Nature.

[51]  G. P. Smith,et al.  Efferent connections and nigral afferents of the nucleus accumbens septi in the rat , 1978, Neuroscience.

[52]  M. Dragunow,et al.  Huntington’s Disease and Neural Transplantation: GABAA Receptor Changes in the Basal Ganglia in Huntington’s Disease in the Human Brain and in the Quinolinic Acid Lesioned Rat Model of the Disease Following Fetal Neuron Transplants , 1995 .

[53]  R. Faull,et al.  The distribution of GABAA-benzodiazepine receptors in the basal ganglia in Huntington's disease and in the quinolinic acid-lesioned rat. , 1993, Progress in brain research.

[54]  W. Wisden,et al.  Function and pharmacology of multiple GABAA receptor subunits. , 1991, Trends in pharmacological sciences.

[55]  Joseph B. Martin,et al.  Differential sparing of somatostatin‐neuropeptide y and cholinergic neurons following striatal excitotoxin lesions , 1989, Synapse.

[56]  John H. Krystal.  Quantitative Receptor Autoradiography , 1987, Nature.

[57]  S. W. Davies,et al.  No evidence for preservation of somatostatin-containing neurons after intrastriatal injections of quinolinic acid , 1987, Nature.

[58]  J. Penney,et al.  Quantitative autoradiography of GABA and benzodiazepine binding in studies of mammalian and human basal ganglia function , 1986 .

[59]  S. Soinila,et al.  Neurohistochemistry, modern methods and applications , 1986 .

[60]  S. Kito,et al.  Autoradiographic studies on benzodiazepine receptor subtypes in the rat brain. , 1985, Japanese journal of pharmacology.

[61]  W. Nauta,et al.  Afferent and efferent relationships of the basal ganglia. , 1984, Ciba Foundation symposium.

[62]  S. Snyder,et al.  Physical separation and characterization of two types of benzodiazepine receptors. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[63]  W. Nauta,et al.  THE ANATOMY OF THE EXTRAPYRAMIDAL SYSTEM , 1979 .